Instrument Inactif

Communiqués ATMI Inc

Actions

US00207R1014

Semi-conducteurs

Communiqués

06/11/19	ATMI : Atara Biotherapeutics to Present Tab-cel® Long-Term Clinical Outcomes from a Multicenter Expanded Access Protocol (EAP) Study for Patients with Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) at the 61st American Soci	PU
20/03/14	ATMI : BlackPak Awarded $4.6M ARPA-E Project for Natural Gas Fuel Tank Technology Development	PR
15/03/14	ATMI : Law Offices of Howard G. Smith : Announces Investigation of ATMI, Inc.	BU
13/03/14	ATMI Inc : Expanding Portfolios with Innovative Products, Acquisitions, and Divestitures - Analyst Notes on Cree, Veeco, Synopsys, Tessera, and ATMI	PR
26/02/14	INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of ATMI Inc. of Class Action Against Its Board of Directors in Connection With the Sale of the Company to Entegris, Inc. -- ATMI	MW
13/02/14	ATMI Inc : INVESTOR ALERT - ATMI INC.: The Law Offices of Vincent Wong Investigates the Sale of ATMI INC. to Entegris, Inc.	BU
06/02/14	ATMI Inc : Ryan & Maniskas, LLP Announces Investigation of ATMI Inc.	PR
05/02/14	ATMI Inc : ATMI, Inc. Stockholders Encouraged to Contact Securities Law Firm about Takeover	PR
05/02/14	ATMI Inc : INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of ATMI Inc. and Its Board of Directors In Connection With the Sale of the Company to Entegris, Inc. -- ATMI	BU
04/02/14	ATMI Inc : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of ATMI, Inc. Stockholders	BU
04/02/14	ATMI Inc : Finkelstein Thompson LLP Investigates Potentially Unfair Buyout of ATMI, Inc.	BU
04/02/14	ATMI Inc : INVESTOR ALERT: LEVI & KORSINSKY, LLP Announces Investigation of ATMI Inc. and Its Board of Directors In Connection With the Sale of the Company to Entegris, Inc.	BU
04/02/14	ATMI Inc : Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of the Proposed Sale of ATMI Inc. to Entegris, Inc.	BU
22/01/14	ATMI to Report Results for the Fourth Quarter of 2013 on February 5, 2014	GL
23/12/13	ATMI Inc : ATMI Announces Agreement to Sell LifeSciences Business to Pall Corporation	PU
01/11/13	ATMI Inc : ATMI Confirms Review of Strategic Alternatives	PU
18/09/13	ATMI Inc : ATMI Introduces Ready-to-Use, Sterile Pyrofree(R) Vials	PU
17/09/13	ATMI Inc : ATMI Announces Technology Investments With Medinstill	PU
05/09/13	ATMI Inc : ATMI Names Patrick J. Shima Chief Legal Officer	PU
22/08/13	ATMI Inc : ATMI to Present at Upcoming Investor Conferences	PU
24/07/13	ATMI Inc : ATMI Reports Revenues and Net Income for the Second Quarter of 2013	PU
11/07/13	ATMI Inc : ATMI to Report Results for Second Quarter of 2013 on July 24, 2013	PU
24/06/13	ATMI Inc : ATMI's Integrity(R) iCELLis(R) Bioreactor Proven for Commercial-Scale Production of Vaccines, Viruses and Proteins	PU
11/06/13	ATMI Inc : ATMI Opens Laboratory for Bioprocess Application Support at Bloomington, MN Site	PU
09/05/13	ATMI Inc : ATMI Extends $2 Million Financial Gift to the University of California, Berkeley to Aid Advanced Research in Mobile Device Efficiency	PU